JP2005525140A - 網状構造を付与した医用移植片デバイス - Google Patents
網状構造を付与した医用移植片デバイス Download PDFInfo
- Publication number
- JP2005525140A JP2005525140A JP2003537689A JP2003537689A JP2005525140A JP 2005525140 A JP2005525140 A JP 2005525140A JP 2003537689 A JP2003537689 A JP 2003537689A JP 2003537689 A JP2003537689 A JP 2003537689A JP 2005525140 A JP2005525140 A JP 2005525140A
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- tissue graft
- collagen
- submucosa
- collagen layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000001519 tissue Anatomy 0.000 claims abstract description 206
- 102000008186 Collagen Human genes 0.000 claims abstract description 78
- 108010035532 Collagen Proteins 0.000 claims abstract description 78
- 229920001436 collagen Polymers 0.000 claims abstract description 78
- 210000004876 tela submucosa Anatomy 0.000 claims abstract description 59
- 239000000463 material Substances 0.000 claims abstract description 53
- 239000002775 capsule Substances 0.000 claims abstract description 48
- 210000003734 kidney Anatomy 0.000 claims abstract description 37
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 7
- 210000002744 extracellular matrix Anatomy 0.000 claims abstract description 7
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims abstract description 6
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims abstract description 6
- 239000010410 layer Substances 0.000 claims description 143
- 238000000034 method Methods 0.000 claims description 47
- 230000006378 damage Effects 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 229940127554 medical product Drugs 0.000 claims description 13
- 238000005304 joining Methods 0.000 claims description 11
- 239000003431 cross linking reagent Substances 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 208000025865 Ulcer Diseases 0.000 claims description 7
- 230000037380 skin damage Effects 0.000 claims description 7
- 231100000397 ulcer Toxicity 0.000 claims description 7
- 210000000416 exudates and transudate Anatomy 0.000 claims description 6
- 238000005755 formation reaction Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 239000002356 single layer Substances 0.000 claims description 5
- 238000004659 sterilization and disinfection Methods 0.000 claims description 5
- 230000018044 dehydration Effects 0.000 claims description 4
- 238000006297 dehydration reaction Methods 0.000 claims description 4
- 208000028990 Skin injury Diseases 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 210000000813 small intestine Anatomy 0.000 claims description 3
- 210000002784 stomach Anatomy 0.000 claims description 3
- 230000000968 intestinal effect Effects 0.000 claims 2
- 208000027418 Wounds and injury Diseases 0.000 abstract description 14
- 206010052428 Wound Diseases 0.000 abstract description 10
- 208000014674 injury Diseases 0.000 abstract description 5
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 238000004132 cross linking Methods 0.000 description 13
- 210000003484 anatomy Anatomy 0.000 description 6
- 238000002054 transplantation Methods 0.000 description 6
- 238000005520 cutting process Methods 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 4
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000003102 growth factor Substances 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 229920000647 polyepoxide Polymers 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- -1 glutaraldehyde Chemical class 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000010030 laminating Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 231100000075 skin burn Toxicity 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- KATAXDCYPGGJNJ-UHFFFAOYSA-N 1,3-bis(oxiran-2-ylmethoxy)propan-2-ol Chemical compound C1OC1COCC(O)COCC1CO1 KATAXDCYPGGJNJ-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- WMGABKFSUGMOEV-UHFFFAOYSA-N 4-amino-1-(hydroxyamino)-1,4-dioxobutane-2-sulfonic acid Chemical class NC(=O)CC(S(O)(=O)=O)C(=O)NO WMGABKFSUGMOEV-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 206010056340 Diabetic ulcer Diseases 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 1
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 208000000558 Varicose Ulcer Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 150000002118 epoxides Chemical group 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 229940126864 fibroblast growth factor Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/10—Hair or skin implants
- A61F2/105—Skin implants, e.g. artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3666—Epithelial tissues other than skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/005—Ingredients of undetermined constitution or reaction products thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Vascular Medicine (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Materials Engineering (AREA)
- Biophysics (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
Claims (35)
- 組織移植片製品において、
粘膜下層組織または腎被膜組織を含んで成るコラーゲン層を備えており、該コラーゲン層には複数のスリットが形成されて網状パターンが付与されている、
ことを特徴とする組織移植片製品。 - 前記コラーゲン層が、腸粘膜下層組織、胃粘膜下層組織、膀胱粘膜下層組織、または子宮粘膜下層組織を含む請求項1記載の組織移植片製品。
- 前記コラーゲン層が、小腸粘膜下層組織を含む請求項2記載の組織移植片製品。
- 前記コラーゲン層が、各々が粘膜下層組織から成る互いに接合された少なくとも2層の材料層を含む請求項1記載の組織移植片製品。
- 各々が粘膜下層組織から成る前記少なくとも2層の材料層が、架橋剤によって互いに接合されている請求項4記載の組織移植片製品。
- 前記少なくとも2層のコラーゲン層が、架橋剤なしで互いに接合されている請求項4記載の組織移植片製品。
- 前記少なくとも2層のコラーゲン層が、脱水加熱接合法によって互いに接合されている請求項6記載の組織移植片製品。
- 各々が粘膜下層組織から成る前記少なくとも2層の材料層が、互いに接合されて実質的に単一層のコラーゲン層を形成している請求項4記載の組織移植片製品。
- 前記少なくとも2層のコラーゲン層が、それらが互いに接している領域の略々全面において互いに接合されている請求項8記載の組織移植片製品。
- 前記網状パターンが、前記コラーゲン層の含水状態における伸展比を約1.2:1以上にするものである請求項1記載の組織移植片製品。
- 前記伸展比が約2:1以上である請求項10記載の組織移植片製品。
- 前記伸展比が約3:1以上である請求項10記載の組織移植片製品。
- 前記網状パターンが、前記コラーゲン層の含水状態における伸展比を約1.2:1以上にするものである請求項4記載の組織移植片製品。
- 各々が粘膜下層組織から成る前記少なくとも2層の材料層の、含水状態における各々の厚さが、約50μm〜約200μmの範囲内にある請求項13記載の組織移植片製品。
- 前記コラーゲン層がシート状である請求項1記載の組織移植片製品。
- 前記コラーゲン層がシート状である請求項14記載の組織移植片製品。
- 患者の開放性皮膚損傷に処置を施す処置方法において、
粘膜下層組織または腎被膜組織を含んで成るコラーゲン層を備えており、該コラーゲン層には複数のスリットが形成されて網状パターンが付与されている組織移植片製品を、開放性皮膚損傷の損傷部位に貼付する、
ことを特徴とする処置方法。 - 前記損傷が熱傷または潰瘍である請求項17記載の処置方法。
- 前記コラーゲン層が、各々が粘膜下層組織から成る少なくとも2層の材料層を含む請求項18記載の処置方法。
- 前記網状パターンが、前記コラーゲン層の含水状態における伸展比を約1.2:1以上にするものである請求項17記載の処置方法。
- 組織移植片製品の製作方法において、
粘膜下層組織または腎被膜組織を含んで成るコラーゲン層を用意し、
前記コラーゲン層に複数のスリットを形成して網状パターンを付与する、
ことを特徴とする製作方法。 - 前記コラーゲン層が、各々が粘膜下層組織から成る互いに接合された少なくとも2層の材料層を含む請求項21記載の製作方法。
- 各々が粘膜下層組織から成る前記少なくとも2層の材料層が、脱水加熱接合法によって互いに接合されている請求項22記載の製作方法。
- 各々が粘膜下層組織から成る前記少なくとも2層の材料層が、架橋剤によって互いに接合されている請求項22記載の製作方法。
- 前記網状パターンが、前記コラーゲン層の含水状態における伸展比を約1.2:1以上にするものである請求項22記載の製作方法。
- 組織移植片構造体において、
少なくとも2層の細胞外基質から成る材料層を互いに接合して多層構造体としたコラーゲン含有層を備えており、前記コラーゲン含有層には複数のスリットが形成されて網状パターンが付与されている、
ことを特徴とする組織移植片構造体。 - 前記コラーゲン含有層が、各々が粘膜下層組織から成る互いに接合された少なくとも2層の材料層を含む請求項26記載の組織移植片構造体。
- 前記粘膜下層組織が、腸粘膜下層組織、胃粘膜下層組織、膀胱粘膜下層組織、または子宮粘膜下層組織である請求項27記載の組織移植片製品。
- 前記粘膜下層組織が、小腸粘膜下層組織である請求項28記載の組織移植片製品。
- 前記網状パターンが、前記コラーゲン含有層の含水状態における伸展比を約1.2:1以上にするものである請求項26記載の組織移植片製品。
- 医用製品において、
滅菌パッケージと、
前記滅菌パッケージの中に封入されており、粘膜下層組織または腎被膜組織を含んで成るコラーゲン層を備えており、該コラーゲン層には複数のスリットが形成されて網状パターンが付与されている組織移植片製品と、
を備えたことを特徴とする医用製品。 - 前記網状パターンが、前記コラーゲン層の含水状態における伸展比を約1.2:1以上にするものである請求項31記載の医用製品。
- 前記コラーゲン層が、各々が粘膜下層組織から成る互いに接合された少なくとも2層の材料層を含む請求項31記載の医用製品。
- 前記コラーゲン層が腎被膜組織を含む請求項31記載の医用製品。
- 滲出性開放性皮膚損傷の処置に用いる組織移植片製品において、
粘膜下層組織または腎被膜組織を含んで成るコラーゲン層を備えており、該コラーゲン層には複数のスリットが形成されており、該複数のスリットの形成個数及び形成間隔は、該組織移植片製品を滲出性開放性皮膚損傷の損傷部位に貼付したときに浸出液の排出が可能なように十分に多くの形成個数及び十分に狭い形成間隔としてあり、こうして浸出液の排出を可能にすることによって損傷部位の組織と該組織移植片製品とが接触した状態を維持できるようにした、
ことを特徴とする組織移植片製品。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34774201P | 2001-10-26 | 2001-10-26 | |
PCT/US2002/034337 WO2003035125A2 (en) | 2001-10-26 | 2002-10-25 | Medical graft device with meshed structure |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010141546A Division JP2010253285A (ja) | 2001-10-26 | 2010-06-22 | 組織移植片製品、及びその使用法及び製作方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2005525140A true JP2005525140A (ja) | 2005-08-25 |
Family
ID=23365067
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003537689A Withdrawn JP2005525140A (ja) | 2001-10-26 | 2002-10-25 | 網状構造を付与した医用移植片デバイス |
JP2010141546A Pending JP2010253285A (ja) | 2001-10-26 | 2010-06-22 | 組織移植片製品、及びその使用法及び製作方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010141546A Pending JP2010253285A (ja) | 2001-10-26 | 2010-06-22 | 組織移植片製品、及びその使用法及び製作方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US8049059B2 (ja) |
EP (1) | EP1438081B1 (ja) |
JP (2) | JP2005525140A (ja) |
AT (1) | ATE390151T1 (ja) |
AU (1) | AU2002336670B2 (ja) |
CA (1) | CA2464661C (ja) |
DE (1) | DE60225824T2 (ja) |
DK (1) | DK1438081T3 (ja) |
WO (1) | WO2003035125A2 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009515569A (ja) * | 2005-10-18 | 2009-04-16 | オーガノジェネシス・インコーポレイテッド | 抗菌性コラーゲン構築物 |
JP2012024253A (ja) * | 2010-07-22 | 2012-02-09 | Nipro Corp | コラーゲン膜及びコラーゲン膜の製造方法 |
JP2012024250A (ja) * | 2010-07-22 | 2012-02-09 | Nipro Corp | コラーゲン膜及びコラーゲン膜の製造方法 |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002336670B2 (en) | 2001-10-26 | 2008-02-07 | Cook Biotech Incorporated | Medical graft device with meshed structure |
US20040260315A1 (en) * | 2003-06-17 | 2004-12-23 | Dell Jeffrey R. | Expandable tissue support member and method of forming the support member |
GB2430626B (en) | 2004-02-09 | 2008-09-24 | Cook Biotech Inc | Stent graft devices having collagen coating |
US20060257447A1 (en) * | 2005-03-09 | 2006-11-16 | Providence Health System | Composite graft |
US9138445B2 (en) * | 2005-03-09 | 2015-09-22 | Cook Biotech Incorporated | Medical graft materials with adherent extracellular matrix fibrous mass |
US7798212B2 (en) * | 2005-04-28 | 2010-09-21 | Schlumberger Technology Corporation | System and method for forming downhole connections |
US7850985B2 (en) | 2005-07-05 | 2010-12-14 | Cook Biotech Incorporated | Tissue augmentation devices and methods |
US9271817B2 (en) * | 2005-07-05 | 2016-03-01 | Cook Biotech Incorporated | Tissue augmentation devices and methods |
EP1919500A2 (en) * | 2005-07-13 | 2008-05-14 | Anthrogenesis Corporation | Treatment of leg ulcers using placenta derived collagen biofabric |
ATE529070T1 (de) * | 2006-07-31 | 2011-11-15 | Organogenesis Inc | Mastopexie- und brustrekonstruktionsprothesen |
EP2079490B1 (en) | 2006-10-23 | 2012-08-29 | Cook Biotech Incorporated | Processed ecm materials with enhanced component profiles |
WO2008060973A1 (en) * | 2006-11-10 | 2008-05-22 | Vance Products Incorporated D/B/A Cook Urological Incorporated | Graft for hysterotomy closure |
US20100136082A1 (en) | 2006-12-22 | 2010-06-03 | Laboratoire Medidom S.A. | In situ system for intra-articular chondral and osseous tissue repair |
US8343536B2 (en) | 2007-01-25 | 2013-01-01 | Cook Biotech Incorporated | Biofilm-inhibiting medical products |
US20080279833A1 (en) * | 2007-05-10 | 2008-11-13 | Matheny Robert G | Laminate sheet articles for tissue regeneration |
CA2736663C (en) | 2007-09-07 | 2018-01-02 | Surgical Biologics, Llc. | Placental tissue grafts and improved methods of preparing and using the same |
US8679176B2 (en) | 2007-12-18 | 2014-03-25 | Cormatrix Cardiovascular, Inc | Prosthetic tissue valve |
US8257434B2 (en) | 2007-12-18 | 2012-09-04 | Cormatrix Cardiovascular, Inc. | Prosthetic tissue valve |
EP2254607B1 (en) * | 2008-03-14 | 2015-04-01 | Cook Biotech Incorporated | Graft materials and methods for staged delivery of bioactive components |
BRPI0914996B1 (pt) * | 2008-06-10 | 2018-10-30 | Cook Biotech Inc | enxerto cirúrgico e método para a fabricação de um enxerto cirúrgico |
US9295757B2 (en) * | 2008-06-10 | 2016-03-29 | Cook Biotech Incorporated | Quilted implantable graft |
AU2009277252B2 (en) | 2008-07-30 | 2014-01-16 | Mesynthes Limited | Tissue scaffolds derived from forestomach extracellular matrix |
ES2553762T3 (es) | 2009-02-18 | 2015-12-11 | Cormatrix Cardiovascular, Inc. | Composiciones y métodos para prevenir la arritmia cardiaca |
US8986377B2 (en) | 2009-07-21 | 2015-03-24 | Lifecell Corporation | Graft materials for surgical breast procedures |
WO2011014704A2 (en) | 2009-07-30 | 2011-02-03 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
EP2394617B1 (de) | 2010-06-10 | 2013-12-11 | MedSkin Solutions Dr. Suwelack AG | Schichtförmige perforierte Biomatrices |
AU2012262538B2 (en) | 2011-05-27 | 2015-09-17 | Cormatrix Cardiovascular, Inc. | Sterilized, acellular extracellular matrix compositions and methods of making thereof |
US10517902B2 (en) * | 2011-09-30 | 2019-12-31 | Prime Merger Sub, Llc | Expandable amnion membrane for treating non-healing wounds |
US9549812B2 (en) | 2012-01-13 | 2017-01-24 | Lifecell Corporation | Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses |
US9532866B2 (en) | 2012-03-15 | 2017-01-03 | L&C Bio Co., Ltd. | Acellular dermal graft |
WO2013137664A1 (ko) * | 2012-03-15 | 2013-09-19 | 주식회사 엘앤씨바이오 | 무세포 진피조직 이식체 |
KR101362403B1 (ko) * | 2012-03-15 | 2014-02-14 | 김준용 | 다중 관통이 형성된 무세포 진피조직 이식체 |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
EP3281607B1 (en) | 2012-06-21 | 2019-03-06 | LifeCell Corporation | Implantable prosthesis having acellular tissue attachments |
EP2903562A1 (en) | 2012-10-04 | 2015-08-12 | Lifecell Corporation | Surgical template and delivery device |
US9526491B2 (en) | 2013-03-08 | 2016-12-27 | William T. MCCLELLAN | Dermal tabs |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
WO2015065923A1 (en) * | 2013-10-28 | 2015-05-07 | The Regents Of The University Of California | Tissue grafts with fenestrations |
US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
CA2985537A1 (en) | 2015-05-15 | 2016-11-24 | Lifecell Corporation | Tissue matrices for plastic surgery |
EP3337427A1 (en) | 2015-08-21 | 2018-06-27 | Lifecell Corporation | Breast treatment device |
US11045579B2 (en) | 2016-08-31 | 2021-06-29 | Lifecell Corporation | Breast treatment device |
US10869745B2 (en) | 2016-10-06 | 2020-12-22 | Lifecell Corporation | Tissue matrix with preformed openings or pilot openings |
CA3055551A1 (en) | 2017-03-06 | 2018-09-13 | Tei Biosciences, Inc. | Perforated tissue graft |
US11426269B2 (en) | 2017-04-20 | 2022-08-30 | The Regents Of The University Of California | Systems and methods for acellular dermal matrix fenestrations in prepectoral breast reconstruction |
EP3911270A4 (en) * | 2019-01-15 | 2022-09-28 | Schultz, Brent | COMPLIANT BIOLOGICAL SCAFFOLDING |
WO2020163471A1 (en) * | 2019-02-06 | 2020-08-13 | Lifecell Corporation | Meshed dermal tissue matrix products |
US10869949B2 (en) * | 2019-04-11 | 2020-12-22 | Geistlich Pharma Ag | Method for treating subjects suffering from chronic ulcers |
US11298220B2 (en) | 2019-05-03 | 2022-04-12 | Lifecell Corporation | Breast treatment device |
US20210393852A1 (en) * | 2020-06-19 | 2021-12-23 | Mimedx Group, Inc. | Meshed umbilical cord tissue grafts |
EP4240437A4 (en) * | 2020-11-05 | 2024-05-29 | MIMEDX Group Inc. | MESH PLACENTAL MEMBRANE TISSUE GRAFTS |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2127903A (en) * | 1936-05-05 | 1938-08-23 | Davis & Geck Inc | Tube for surgical purposes and method of preparing and using the same |
US3358688A (en) * | 1964-01-15 | 1967-12-19 | Jr James C Tanner | Method of preparing skin for use in a skin graft |
US3472228A (en) * | 1965-03-15 | 1969-10-14 | Tanner James C Jun | Apparatus for preparing skin grafts |
US3640279A (en) * | 1967-12-07 | 1972-02-08 | Warren F Brown | Skin graft cutting method and machine |
US4956178A (en) * | 1988-07-11 | 1990-09-11 | Purdue Research Foundation | Tissue graft composition |
US4902508A (en) * | 1988-07-11 | 1990-02-20 | Purdue Research Foundation | Tissue graft composition |
US5004468A (en) * | 1989-07-03 | 1991-04-02 | Zimmer | Skin graft preparation apparatus |
US5281422A (en) * | 1991-09-24 | 1994-01-25 | Purdue Research Foundation | Graft for promoting autogenous tissue growth |
US6653291B1 (en) | 1992-11-13 | 2003-11-25 | Purdue Research Foundation | Composition and method for production of transformed cells |
US5641518A (en) * | 1992-11-13 | 1997-06-24 | Purdue Research Foundation | Method of repairing bone tissue |
US5352463A (en) * | 1992-11-13 | 1994-10-04 | Badylak Steven F | Tissue graft for surgical reconstruction of a collagenous meniscus and method therefor |
US5275826A (en) * | 1992-11-13 | 1994-01-04 | Purdue Research Foundation | Fluidized intestinal submucosa and its use as an injectable tissue graft |
US5902279A (en) | 1993-04-20 | 1999-05-11 | Advanced Cytometrix, Inc. | Aspiration needle and method |
US5942496A (en) | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
US6475232B1 (en) * | 1996-12-10 | 2002-11-05 | Purdue Research Foundation | Stent with reduced thrombogenicity |
US5695998A (en) | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
US5711969A (en) * | 1995-04-07 | 1998-01-27 | Purdue Research Foundation | Large area submucosal tissue graft constructs |
US5733337A (en) * | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
US5554389A (en) * | 1995-04-07 | 1996-09-10 | Purdue Research Foundation | Urinary bladder submucosa derived tissue graft |
EP0820301B1 (en) * | 1995-04-07 | 2002-07-24 | Purdue Research Foundation | Tissue graft for urinary bladder reconstruction |
US5693094A (en) * | 1995-05-09 | 1997-12-02 | Allergan | IOL for reducing secondary opacification |
JP3554412B2 (ja) * | 1995-08-07 | 2004-08-18 | 株式会社メニコン | 培養皮膚用基材、培養皮膚およびその製造法 |
WO1997006837A1 (en) * | 1995-08-16 | 1997-02-27 | Integra Lifesciences Corporation | Perforated artificial skin grafts |
IL116282A (en) * | 1995-12-07 | 2000-10-31 | L R Surgical Instr Ltd | Adjustable mesher device and a system for using the same |
US5755791A (en) * | 1996-04-05 | 1998-05-26 | Purdue Research Foundation | Perforated submucosal tissue graft constructs |
US6171344B1 (en) * | 1996-08-16 | 2001-01-09 | Children's Medical Center Corporation | Bladder submucosa seeded with cells for tissue reconstruction |
CZ54899A3 (cs) * | 1996-08-23 | 1999-08-11 | Cook Biotech, Incorporated | Štěpová protéza, materiály s ní spojené a způsoby její výroby |
DE69720252T2 (de) | 1996-12-10 | 2003-12-04 | Purdue Research Foundation, West Lafayette | Gewebetransplantat aus der magensubmukosa |
WO1998025545A1 (en) * | 1996-12-10 | 1998-06-18 | Cook Biotech, Inc. | Stent grafts containing purified submucosa |
JP4638562B2 (ja) | 1996-12-10 | 2011-02-23 | パーデュー・リサーチ・ファウンデーション | 脊椎動物肝臓組織由来の生物材料 |
US5993844A (en) * | 1997-05-08 | 1999-11-30 | Organogenesis, Inc. | Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix |
WO1999062431A1 (en) | 1998-06-02 | 1999-12-09 | Cook Incorporated | Multiple-sided intraluminal medical device |
CA2334364C (en) * | 1998-06-05 | 2011-01-04 | Organogenesis Inc. | Bioengineered flat sheet graft prostheses |
DK1207819T3 (da) * | 1999-08-06 | 2009-06-02 | Cook Biotech Inc | Rörformet transplantatkonstruktion |
ATE488195T1 (de) | 1999-09-10 | 2010-12-15 | Cook Inc | Endovaskuläre behandlung chronischer venöser insuffizienz |
WO2002022184A2 (en) * | 2000-09-18 | 2002-03-21 | Organogenesis Inc. | Bioengineered flat sheet graft prosthesis and its use |
EP1404388B1 (en) * | 2001-06-28 | 2013-10-23 | Cook Biotech, Inc. | Graft prosthesis devices containing renal capsule collagen |
AU2002336670B2 (en) | 2001-10-26 | 2008-02-07 | Cook Biotech Incorporated | Medical graft device with meshed structure |
-
2002
- 2002-10-25 AU AU2002336670A patent/AU2002336670B2/en not_active Expired
- 2002-10-25 DK DK02773918T patent/DK1438081T3/da active
- 2002-10-25 US US10/493,458 patent/US8049059B2/en active Active
- 2002-10-25 AT AT02773918T patent/ATE390151T1/de not_active IP Right Cessation
- 2002-10-25 DE DE60225824T patent/DE60225824T2/de not_active Expired - Lifetime
- 2002-10-25 JP JP2003537689A patent/JP2005525140A/ja not_active Withdrawn
- 2002-10-25 WO PCT/US2002/034337 patent/WO2003035125A2/en active Application Filing
- 2002-10-25 CA CA2464661A patent/CA2464661C/en not_active Expired - Lifetime
- 2002-10-25 EP EP02773918A patent/EP1438081B1/en not_active Expired - Lifetime
-
2010
- 2010-06-22 JP JP2010141546A patent/JP2010253285A/ja active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009515569A (ja) * | 2005-10-18 | 2009-04-16 | オーガノジェネシス・インコーポレイテッド | 抗菌性コラーゲン構築物 |
JP2012024253A (ja) * | 2010-07-22 | 2012-02-09 | Nipro Corp | コラーゲン膜及びコラーゲン膜の製造方法 |
JP2012024250A (ja) * | 2010-07-22 | 2012-02-09 | Nipro Corp | コラーゲン膜及びコラーゲン膜の製造方法 |
Also Published As
Publication number | Publication date |
---|---|
CA2464661A1 (en) | 2003-05-01 |
DE60225824T2 (de) | 2009-04-16 |
CA2464661C (en) | 2011-11-29 |
EP1438081B1 (en) | 2008-03-26 |
WO2003035125A2 (en) | 2003-05-01 |
US20050021141A1 (en) | 2005-01-27 |
US8049059B2 (en) | 2011-11-01 |
ATE390151T1 (de) | 2008-04-15 |
EP1438081A2 (en) | 2004-07-21 |
WO2003035125A3 (en) | 2003-06-05 |
DK1438081T3 (da) | 2008-07-07 |
JP2010253285A (ja) | 2010-11-11 |
DE60225824D1 (de) | 2008-05-08 |
AU2002336670B2 (en) | 2008-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2005525140A (ja) | 網状構造を付与した医用移植片デバイス | |
AU2002336670A1 (en) | Medical graft device with meshed structure | |
RU2481114C2 (ru) | Биоинженерный коллагеновый конструкт, модифицированный кишечный коллагеновый слой, переработанный тканевый матрикс и способ восстановления или замещения поврежденной ткани | |
EP2254607B1 (en) | Graft materials and methods for staged delivery of bioactive components | |
ES2733313T3 (es) | Método para la reparación de ligamento o tendón | |
CA2634316C (en) | Wound dressing comprising cross-linked, hydrogen bonding-altered, sterilized animal tissue and bioactive materials and a method of making | |
CA2678449C (en) | Biofilm-inhibiting medical products | |
US11813143B2 (en) | Tissue care devices including microstructures | |
US5300306A (en) | Tissue-equivalent membrane from bovine esophageal tissue | |
Jürgens et al. | Biodegradable films in trauma and orthopedic surgery | |
US9023342B2 (en) | Tissue grafting method | |
KR20230160900A (ko) | 상처 치료제, 및 상처 안정화, 보호 및 치료 방법 | |
RU2542432C1 (ru) | Способ изготовления пластины на основе модифицированной ксеногенной подслизистой оболочки тонкой кишки | |
CN117460544A (zh) | 稳定、保护和治疗伤口的伤口治疗物及方法 | |
GRZYBOWSKI | 7.3 EVALUATION OF COLLAGEN MEMBRANES AS BIOLOGICAL DRESSINGS | |
MX2008005125A (en) | Antimicrobial collagenous constructs | |
Campbell | Practical applications of porcine submucosal products. | |
CA2120385A1 (en) | Tissue-equivalent membrane from bovine esophageal tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20051013 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090608 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090908 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090915 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091208 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20091208 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20100222 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100622 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20100629 |